Contribution of quantitative assay technics to the understanding of the clinical pharmacology of digitalis.
D000251:Adenosine Triphosphatases / Q000378:metabolism; D000818:Animals; D001345:Autoradiography; D001681:Biological Assay; D002849:Chromatography, Gas; D004071:Digitalis Glycosides / Q000627:therapeutic use*; D004074:Digitoxin / Q000009:adverse effects / Q000097:blood / Q000627:therapeutic use; D004077:Digoxin / Q000009:adverse effects / Q000097:blood / Q000627:therapeutic use; D004347:Drug Interactions; D004372:Ducks / Q000196:embryology; D004912:Erythrocytes / Q000201:enzymology; D006801:Humans; D010042:Ouabain / Q000097:blood / Q000627:therapeutic use; D010634:Phenobarbital / Q000627:therapeutic use; D010653:Phenylbutazone / Q000627:therapeutic use; D011188:Potassium / Q000378:metabolism; D011863:Radioimmunoassay; D011865:Radioisotope Dilution Technique; D011868:Radioisotopes; D012413:Rubidium; D012964:Sodium / Q000378:metabolism
D004071:Digitalis Glycosides; D011868:Radioisotopes; D010042:Ouabain; D004077:Digoxin; D012964:Sodium; D004074:Digitoxin; D000251:Adenosine Triphosphatases; D010653:Phenylbutazone; D012413:Rubidium; D011188:Potassium; D010634:Phenobarbital